US Stock MarketDetailed Quotes
QNTM Quantum BioPharma
- 4.550
- -0.440-8.82%
Close Nov 27 16:00 ET
- 4.785
- +0.235+5.16%
Post 20:01 ET
8.73MMarket Cap-329P/E (TTM)
4.980High4.380Low118.42KVolume4.980Open4.990Pre Close541.97KTurnover7.43%Turnover RatioLossP/E (Static)1.92MShares70.85052wk High0.54P/B7.26MFloat Cap3.50052wk Low--Dividend TTM1.59MShs Float910.000Historical High--Div YieldTTM12.02%Amplitude3.500Historical Low4.576Avg Price1Lot Size
Quantum BioPharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 60.18%-10.83M | 86.54%-851.65K | 77.21%-1.71M | 59.94%-3.51M | -3.59%-4.75M | -40.42%-27.19M | -60.76%-6.33M |
| Net income from continuing operations | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M | 31.73%-18.23M | 73.14%-1.65M | 84.13%-1.13M | 31.07%-5.49M | -82.34%-9.96M | 21.32%-26.7M | 0.24%-6.15M |
| Operating gains losses | -3,341.25%-260.34K | 150.18%164.68K | 133.89%484.04K | -244.50%-595.77K | -165.72%-482.56K | -98.89%8.03K | -205.21%-328.19K | 146.76%206.95K | 160.41%412.29K | 72.63%-181.6K |
| Depreciation and amortization | -17.71%120.81K | -87.65%136.81K | -89.37%120.14K | -44.73%2.51M | -89.41%122.22K | -87.19%146.81K | -2.28%1.11M | 2.61%1.13M | 12.09%4.53M | 4.23%1.15M |
| Other non cash items | 100.52%10.37K | 100.29%8.36K | 423.14%12.41K | -6,147.98%-4.91M | 118.26%3.09K | -11,099.61%-2.01M | -15,227.04%-2.91M | 103.76%2.37K | -501.09%-78.66K | -157.90%-16.91K |
| Change In working capital | -46.04%618.21K | 1,126.30%2.32M | -245,168.28%-556.31K | 123.00%1.64M | 145.67%718.33K | 140.56%1.15M | 91.90%-226.51K | -99.69%227 | -346.49%-7.12M | -314.01%-1.57M |
| -Change in receivables | -220.15%-524.65K | 232.14%1.15M | 349.13%610.74K | 89.90%-728.72K | 96.59%-49.7K | 114.51%436.67K | 66.25%-870.54K | -43.69%-245.15K | -6,651.95%-7.22M | -1,539.51%-1.46M |
| -Change in prepaid assets | -112.90%-19.9K | -57.39%142.67K | 67.79%-117.68K | -60.21%316.72K | -66.98%192.95K | -59.85%154.32K | 1,404.71%334.86K | -87.37%-365.4K | 230.66%795.93K | 1,475.19%584.31K |
| -Change in payables and accrued expense | 109.60%1.16M | 233.69%1.03M | -271.81%-1.05M | 392.92%2.05M | --575.08K | --554.77K | 229.63%309.17K | 39.24%610.78K | -119.41%-699.78K | ---- |
| Cash from discontinued investing activities | 0 | 17.30%-1.14M | 0 | |||||||
| Operating cash flow | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 61.79%-10.83M | 86.54%-851.65K | 77.21%-1.71M | 62.66%-3.51M | 6.66%-4.75M | -36.57%-28.33M | -54.64%-6.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,184.78%-3.46M | 738.22K | -22.14K | 55.63%-269.58K | 0 | -178.15%-269.58K | 0 | 0 | -325.88%-607.53K | -919.64%-392.53K |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---113.96K | --2.92K |
| Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 50.00%-250K | --0 |
| Net business purchase and sale | ---- | ---- | ---- | --31.78K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | -1,049.28%-3.46M | --738.22K | ---22.14K | -23.72%-301.36K | --0 | ---301.36K | --0 | --0 | ---243.58K | ---395.45K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,184.78%-3.46M | --738.22K | ---22.14K | -102.22%-269.58K | --0 | -178.15%-269.58K | --0 | --0 | 4,407.45%12.12M | -919.64%-392.53K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 12,400.66%6.74M | 4,378.90%1.84M | 118.94%568.72K | -51.09%-3.13M | 49.10%-25.22K | 78.75%-54.78K | 84.34%-43.11K | -102.02%-3M | -105.42%-2.07M | -283.67%-49.54K |
| Net issuance payments of debt | -461.21%-307.41K | 102.39%1.31K | 601.31%272.28K | -32.14%-189.05K | 49.03%-25.25K | -35.38%-54.78K | -32.70%-54.71K | -358.81%-54.31K | -10.63%-143.07K | -283.67%-49.54K |
| Net common stock issuance | --7.05M | --1.84M | 110.02%296.44K | -53.55%-2.96M | --34 | --0 | --0 | -100.54%-2.96M | -105.02%-1.93M | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --20.25K | --0 | --0 | --11.6K | --8.65K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 12,400.66%6.74M | 4,378.90%1.84M | 118.94%568.72K | -51.09%-3.13M | 49.10%-25.22K | 78.75%-54.78K | 84.34%-43.11K | -102.02%-3M | -105.42%-2.07M | -283.67%-49.54K |
| Net cash flow | ||||||||||
| Beginning cash position | -41.69%3.31M | -85.58%1.33M | -83.76%2.76M | -51.84%16.98M | -84.70%3.63M | -82.07%5.67M | -67.72%9.22M | -51.84%16.98M | 101.20%35.26M | -39.59%23.75M |
| Current changes in cash | 90.85%-186.42K | 155.64%1.98M | 81.61%-1.43M | 22.19%-14.22M | 87.04%-876.87K | 74.12%-2.04M | -216.61%-3.55M | -16.01%-7.76M | -203.07%-18.28M | -66.88%-6.77M |
| End cash Position | -14.14%3.12M | -41.69%3.31M | -85.58%1.33M | -83.76%2.76M | -83.76%2.76M | -84.70%3.63M | -82.07%5.67M | -67.72%9.22M | -51.84%16.98M | -51.84%16.98M |
| Free cash flow | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M | 62.27%-10.83M | 86.53%-851.65K | 77.50%-1.71M | 62.68%-3.51M | 11.27%-4.75M | -35.07%-28.7M | -56.40%-6.32M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data